Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major

Similar Items

• New strategies to target iron metabolism for the treatment of beta thalassemia
  od: Oikonomidou, Paraskevi Rea, i dr.
  Izdano: (2016)
• Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
  od: Casu, Carla, i dr.
  Izdano: (2016)
• What can we learn from ineffective erythropoiesis in thalassemia?
  od: Oikonomidou, Paraskevi Rea, i dr.
  Izdano: (2017)
• Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemia
  od: Guerra, Amaliris, i dr.
  Izdano: (2019)
• Genetic loss of Tmprss6 alters terminal erythroid differentiation in a mouse model of β-thalassemia intermedia
  od: Stagg, David B., i dr.
  Izdano: (2019)